$HRGN
Harvard Apparatus Regenerative Technology Inc

2015 Q2 Form 10-Q Financial Statement

#000114420415049940 Filed on August 14, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $73.00K $23.00K
YoY Change 217.39%
Cost Of Revenue $37.00K $12.00K
YoY Change 208.33%
Gross Profit $36.00K $11.00K
YoY Change 227.27%
Gross Profit Margin 49.32% 47.83%
Selling, General & Admin $3.482M $1.330M
YoY Change 161.8% 62.2%
% of Gross Profit 9672.22% 12090.91%
Research & Development $1.050M $1.214M
YoY Change -13.51% -4.41%
% of Gross Profit 2916.67% 11036.36%
Depreciation & Amortization $120.0K $90.00K
YoY Change 33.33% 125.0%
% of Gross Profit 333.33% 818.18%
Operating Expenses $4.535M $2.544M
YoY Change 78.26% 21.78%
Operating Profit -$4.499M -$2.533M
YoY Change 77.62% 21.25%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$4.499M -$2.533M
YoY Change 77.62% 21.25%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.499M -$2.533M
YoY Change 77.62% 21.25%
Net Earnings / Revenue -6163.01% -11013.04%
Basic Earnings Per Share
Diluted Earnings Per Share -$8.654M -$6.487M
COMMON SHARES
Basic Shares Outstanding 7.812M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.13M $10.07M
YoY Change 0.6%
Cash & Equivalents $10.13M $10.07M
Short-Term Investments
Other Short-Term Assets $170.0K $360.0K
YoY Change -52.78%
Inventory $200.0K $150.0K
Prepaid Expenses
Receivables $81.00K
Other Receivables $0.00
Total Short-Term Assets $10.58M $10.65M
YoY Change -0.66%
LONG-TERM ASSETS
Property, Plant & Equipment $1.200M $1.038M
YoY Change 15.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.200M $1.038M
YoY Change 15.61%
TOTAL ASSETS
Total Short-Term Assets $10.58M $10.65M
Total Long-Term Assets $1.200M $1.038M
Total Assets $11.78M $11.69M
YoY Change 0.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $320.0K $434.0K
YoY Change -26.27%
Accrued Expenses $220.0K $350.0K
YoY Change -37.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $590.0K $825.0K
YoY Change -28.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $590.0K $825.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $590.0K $825.0K
YoY Change -28.48%
SHAREHOLDERS EQUITY
Retained Earnings -$7.513M
YoY Change
Common Stock $110.0K $78.00K
YoY Change 41.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.19M $10.86M
YoY Change
Total Liabilities & Shareholders Equity $11.78M $11.69M
YoY Change 0.8%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$4.499M -$2.533M
YoY Change 77.62% 21.25%
Depreciation, Depletion And Amortization $120.0K $90.00K
YoY Change 33.33% 125.0%
Cash From Operating Activities -$2.020M -$2.400M
YoY Change -15.83% 26.32%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$260.0K
YoY Change -96.15% 766.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K -$260.0K
YoY Change -96.15% 766.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 110.0K
YoY Change -100.0% -94.3%
NET CHANGE
Cash From Operating Activities -2.020M -2.400M
Cash From Investing Activities -10.00K -260.0K
Cash From Financing Activities 0.000 110.0K
Net Change In Cash -2.030M -2.550M
YoY Change -20.39%
FREE CASH FLOW
Cash From Operating Activities -$2.020M -$2.400M
Capital Expenditures -$10.00K -$260.0K
Free Cash Flow -$2.010M -$2.140M
YoY Change -6.07% 14.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
110000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
79000 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27468000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
11191000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11781000 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10974388 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7856607 shares
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-144000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-65000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-83000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
39000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-49000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-54000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
189000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3710000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3809000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
495000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-495000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3237000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
358000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8594000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
358000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4855000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3943000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10127000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10065000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
5357000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
CY2013Q4 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
15000000 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1100000 USD
CY2015Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
9700000 USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5000 USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
76000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
837000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
611000 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10974388 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7856607 shares
CY2015Q1 hart Proceeds From Issuance Of Stock To Underwriters
ProceedsFromIssuanceOfStockToUnderwriters
8600000 USD

Files In Submission

Name View Source Status
0001144204-15-049940-index-headers.html Edgar Link pending
0001144204-15-049940-index.html Edgar Link pending
0001144204-15-049940.txt Edgar Link pending
0001144204-15-049940-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hart-20150630.xml Edgar Link completed
hart-20150630.xsd Edgar Link pending
hart-20150630_cal.xml Edgar Link unprocessable
hart-20150630_def.xml Edgar Link unprocessable
hart-20150630_lab.xml Edgar Link unprocessable
hart-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v417630_10q.htm Edgar Link pending
v417630_ex10-1.htm Edgar Link pending
v417630_ex31-1.htm Edgar Link pending
v417630_ex31-2.htm Edgar Link pending
v417630_ex32-1.htm Edgar Link pending
v417630_ex32-2.htm Edgar Link pending